524731
vs
B
BSE Sensex 30
524731
Over the past 12 months, JENBURPH has outperformed BSE Sensex 30, delivering a return of 0% compared to the BSE Sensex 30's 5% drop.
Stocks Performance
524731 vs BSE Sensex 30
Performance Gap
524731 vs BSE Sensex 30
Performance By Year
524731 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Jenburkt Pharmaceuticals Ltd
Glance View
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The company is headquartered in Mumbai, Maharashtra and currently employs 730 full-time employees. The firm offers pharmaceutical products for various therapeutic areas, analgesic and antipyretics anthelmintics, anti-arthritic, anti-diabetics, anti-infectives, antifungals, antimalarials, antiulcerants/antacids, aphrodisiac, consumer division, cough and cold, muscle relaxants neuropathic pain, nutraceuticals and pain management. The firm's product brands include Allerzine tablets, Cartisafe forte MSM tablets, Eberjen Cream and SOL, ECOPROT powder, Frendacid suspension, Fundu tablets, Glajen-E capsules, GLUCOTROL tablets, Jenflam tablets, Lutriben cream, Ornel tablets, Pantazole tablets and others. The firm's manufacturing plant is located in Sihor-Gujarat. The firm's products are exported to approximately 13 countries globally.
